Who owns Revolution Medicines, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of RVMD from SEC Form 13F filings across 756 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 756 institutions disclosed 212.1M shares of Revolution Medicines, Inc. worth $43.46B — about 98.7% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
756
13F holders
$43.46B
value, 2026 filers
98.7%
of shares outstanding (212.1M sh)
145
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of RVMD's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 15.4M | $3.16B | 0.1% | 7.2% | +26.2% |
| 2 | BlackRock, Inc. | 13.9M | $2.84B | 0.0% | 6.4% | +1.2% |
| 3 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 13.4M | $2.75B | 11.9% | 6.2% | -1.0% |
| 4 | BAKER BROS. ADVISORS LP | 10.6M | $2.18B | 10.4% | 4.9% | -7.0% |
| 5 | Darwin Global Management, Ltd. | 10.6M | $2.18B | 54.7% | 4.9% | 0.0% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 9.1M | $1.88B | 0.0% | 4.3% | +0.7% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.2M | $1.67B | 0.1% | 3.8% | -1.7% |
| 8 | Nextech Invest Ltd. | 7.6M | $1.56B | 69.9% | 3.5% | 0.0% |
| 9 | Janus Henderson Group Ltd.NEW | 7.6M | $1.56B | 0.7% | 3.5% | new |
| 10 | Paradigm Biocapital Advisors LP | 6.2M | $1.28B | 25.4% | 2.9% | -2.2% |
| 11 | Capital World Investors | 5.5M | $1.12B | 0.1% | 2.5% | +36.2% |
| 12 | STATE STREET CORP | 5.1M | $1.04B | 0.0% | 2.4% | +3.4% |
| 13 | JPMORGAN CHASE & CO | 4.7M | $973.1M | 0.1% | 2.2% | +43.9% |
| 14 | UBS Group AG | 4.6M | $941.0M | 0.1% | 2.1% | -15.9% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 4.0M | $832.1M | 0.0% | 1.9% | +1.6% |
| 16 | WELLINGTON MANAGEMENT GROUP LLP | 3.1M | $642.7M | 0.1% | 1.5% | -18.5% |
| 17 | Alphabet Inc. | 2.7M | $548.8M | 0.6% | 1.2% | -9.3% |
| 18 | Casdin Capital, LLC | 2.6M | $529.0M | 23.0% | 1.2% | 0.0% |
| 19 | BVF INC/IL | 2.5M | $505.1M | 16.6% | 1.1% | -17.0% |
| 20 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.3M | $481.8M | 0.2% | 1.1% | +16.7% |
| 21 | Assenagon Asset Management S.A. | 2.2M | $447.7M | 0.4% | 1% | +987.9% |
| 22 | Avoro Capital Advisors LLC | 2.1M | $440.3M | 4.5% | 1% | -6.6% |
| 23 | DEERFIELD MANAGEMENT COMPANY, L.P. | 2.1M | $436.0M | 6.7% | 1% | -11.2% |
| 24 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.0M | $405.9M | 0.0% | 0.9% | -17.3% |
| 25 | Caligan Partners LP | 2.0M | $402.7M | 24.6% | 0.9% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.